Qlife Holding shareholders will vote on 1 December 2026 regarding a directed issue of 3.77 million shares and accompanying warrants to fund business operations, deviating from existing preferential rights.
Shareholders are called to an EGM on 1 December 2026 to approve a directed issue of up to 3,774,806 shares at 0.93 kronor plus free TO9 warrants (strike 1.86 kronor, exercisable November-December 2028), raising capital for the business strategy. The subscription price is set via accelerated bookbuilding at only about 0.5% below the 10-day VWAP, so it is market-based, but the issue deviates from shareholders' preferential rights and dilutes existing holders. The capital injection supports the strategy, while the dilution offsets it.
Qlife Holding AB has summoned shareholders to an extraordinary general meeting on 1 December 2026 to approve a directed share issue. The proposal, initiated by JEQ Capital AB, involves issuing up to 3,774,806 shares at 0.93 kronor each, accompanied by 1,887,403 free series TO9 warrants. The capital raise aims to support the company's business strategy, with the subscription price set at a 0.5% discount to the 10-day volume-weighted average price.
On 1 December 2026 shareholders will vote on a shareholder proposal from JEQ Capital AB for a directed issue of up to 3,774,806 shares at 0.93 kronor each and 1,887,403 free series TO9 warrants, excluding existing shareholders' preferential rights.
Two subscribed shares entitle the holder to one TO9 warrant, obtained free of charge. Each warrant allows subscription of one new share at 1.86 kronor between 13 November 2028 and 12 December 2028.